Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jarmila Šimová"'
Autor:
Tomas Kupka, Jarmila Simova, Jana Dvorackova, Lubomir Martinek, Oldrich Motyka, Magdalena Uvirova, Petr Dite
Publikováno v:
Biomedical Papers, Vol 162, Iss 2, Pp 139-143 (2018)
Background and Objectives. Crohn's disease is a multifactorial inflammatory disease affecting mainly the gastrointestinal tract. The genetic factors that are involved in the disease include mainly three mutations of the gene NOD2/CARD15 (R702W, G908R
Externí odkaz:
https://doaj.org/article/bd9f1a9394064c53ad0c89ace844ba03
Autor:
Rastislav Slavkovský, Jana Stránská, Veronika Věnsková, Sylwia Jančik, Lucie Kotková, Jarmila Šimová, Petr Vojta, Patrik Flodr, Marie Bartoušková, Hana Študentová, Marián Hajdúch, Jiří Drábek
Publikováno v:
Neoplasma. 69:203-215
The presence of wild-type RAS alleles, as determined by genotyping codons 12, 13, 59, 61, 117, and 146, is a prerequisite for personalized anti-EGFR treatment of metastatic colorectal cancer (mCRC) patients. Here we describe analytical validation of
Autor:
Róbert, Ondruššek, Jana, Žmolíková, Jarmila, Šimová, Petra, Bartová, Pavel, Hurník, Magdalena, Uvírová, Dušan, Žiak
Publikováno v:
American Journal of Case Reports. 23
BACKGROUND Histiocytic sarcoma is a rare malignant hematopoietic neoplasm with morphologic and immunohistochemical features of histiocytic differentiation, usually with unfavorable prognosis. Despite aggressive biological behavior, in subgroup of pat
Autor:
Arpád Bóday, Ivana Tichá, Jarmila Šimová, Jiří Drábek, Ales Ryska, Markéta Kalinová, Hana Vošmiková, Milada Matějčková, Jitka Berkovcová, Ondřej Horký, Petr Martínek, Kateřina Sieglová
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 30(3)
Background Malignant melanoma is - in comparison with other skin tumors - a relatively rare malignant neoplasm with highly aggressive biologic behavior and variable prognosis. Recent data in pathology and molecular diagnostics indicate that malignant
Autor:
Magdalena Uvirova, Jarmila Simova, Barbora Kubovaª, Nina Dvorackova, Hana Tomaskova, Monika Sedivcova, Petr Dite
Publikováno v:
Biomedical Papers, Vol 159, Iss 3, Pp 466-471 (2015)
Aims: A germline SNP (rs61764370) is located in a let-7 complementary site (LCS6) in the 3'UTR of KRAS oncogene, and it was found to alter the binding capability of the mature let-7 microRNA to the KRAS mRNA. The aim of the study was to evaluate the
Externí odkaz:
https://doaj.org/article/608ed63ebd43463697df526a68b93257